SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-120199
Filing Date
2020-04-27
Accepted
2020-04-27 07:30:57
Documents
7
Period of Report
2020-06-09
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d889039ddef14a.htm DEF 14A 328983
2 GRAPHIC g889039g11p21.jpg GRAPHIC 23775
3 GRAPHIC g889039g17d86.jpg GRAPHIC 112273
4 GRAPHIC g889039g31o79.jpg GRAPHIC 28076
5 GRAPHIC g889039g77w99.jpg GRAPHIC 130289
6 GRAPHIC g889039g81l50.jpg GRAPHIC 26183
7 GRAPHIC g889039g90r10.jpg GRAPHIC 38062
  Complete submission text file 0001193125-20-120199.txt   818009
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39114 | Film No.: 20817235
SIC: 2834 Pharmaceutical Preparations